Filter news stories by category:
- UCLH news
- Charity news
-
Research news
- Governors news
- Red Cell Network news
- HTD news
- Reset filter
-
Research news
13 May 2021
Over 1000 breathing aids developed by UCLH and UCL have been sent to India to help with the surge in Covid-19 cases.
-
Research news
12 May 2021
UCLH Director of Research Professor Bryan Williams and Consultant Neuropsychologist at UCLH Professor Lisa Cipolotti have been elected Fellows of the Academy of Medical Sciences in recognition of their exceptional contributions to biomedical and health science.
-
Research news
10 May 2021
Mild Covid-19 infection is very unlikely to cause lasting damage to the structure or function of the heart, according to a study supported by the NIHR UCLH Biomedical Research Centre and UCLH Charity.
-
Research news
07 May 2021
UCLH is to lead an initiative to improve care for myeloma patients alongside Oxford University Hospitals NHS Foundation Trust (OUH) and University Hospital Southampton NHS Foundation Trust (UHS).
-
Research news
07 May 2021
Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
-
Research news
30 April 2021
A single dose of the Pfizer Covid-19 vaccine may boost protection against Covid-19 variants for those who have previously had the virus, according to a new study supported by the NIHR UCLH Biomedical Research Centre and UCLH Charity.
-
Research news
26 April 2021
Volunteers are being asked to sign up to the latest Covid-19 vaccine study to begin across the UK including at UCLH.
-
Research news
16 April 2021
UCLH-led research paper outlines mechanism behind rare cases of blood clots and low platelets after vaccination
-
Research news
14 April 2021
A study of patients at UCLH and North Middlesex University Hospital published in The Lancet Infectious Diseases suggests that the B.1.17. variant of Covid-19 is not associated with more severe illness and death, but appears to lead to higher virus load.
-
Research news
14 April 2021
The Com-Cov trial in which UCLH is a site looking at alternating vaccines has been expanded to include the Moderna and Novavax vaccines.